Cargando…

Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review

Detalles Bibliográficos
Autores principales: Manti, Sara, Parisi, Giuseppe Fabio, Papale, Maria, Marseglia, Gian Luigi, Licari, Amelia, Leonardi, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860524/
https://www.ncbi.nlm.nih.gov/pubmed/33434384
http://dx.doi.org/10.1002/iid3.384
_version_ 1783646906930429952
author Manti, Sara
Parisi, Giuseppe Fabio
Papale, Maria
Marseglia, Gian Luigi
Licari, Amelia
Leonardi, Salvatore
author_facet Manti, Sara
Parisi, Giuseppe Fabio
Papale, Maria
Marseglia, Gian Luigi
Licari, Amelia
Leonardi, Salvatore
author_sort Manti, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-7860524
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78605242021-02-05 Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review Manti, Sara Parisi, Giuseppe Fabio Papale, Maria Marseglia, Gian Luigi Licari, Amelia Leonardi, Salvatore Immun Inflamm Dis Editorial John Wiley and Sons Inc. 2021-01-12 /pmc/articles/PMC7860524/ /pubmed/33434384 http://dx.doi.org/10.1002/iid3.384 Text en © 2020 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Manti, Sara
Parisi, Giuseppe Fabio
Papale, Maria
Marseglia, Gian Luigi
Licari, Amelia
Leonardi, Salvatore
Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
title Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
title_full Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
title_fullStr Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
title_full_unstemmed Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
title_short Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
title_sort clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: our experience and literature review
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860524/
https://www.ncbi.nlm.nih.gov/pubmed/33434384
http://dx.doi.org/10.1002/iid3.384
work_keys_str_mv AT mantisara clinicalefficacyandsafetyofomalizumabinconventionaltreatmentresistantvernalkeratoconjunctivitisourexperienceandliteraturereview
AT parisigiuseppefabio clinicalefficacyandsafetyofomalizumabinconventionaltreatmentresistantvernalkeratoconjunctivitisourexperienceandliteraturereview
AT papalemaria clinicalefficacyandsafetyofomalizumabinconventionaltreatmentresistantvernalkeratoconjunctivitisourexperienceandliteraturereview
AT marsegliagianluigi clinicalefficacyandsafetyofomalizumabinconventionaltreatmentresistantvernalkeratoconjunctivitisourexperienceandliteraturereview
AT licariamelia clinicalefficacyandsafetyofomalizumabinconventionaltreatmentresistantvernalkeratoconjunctivitisourexperienceandliteraturereview
AT leonardisalvatore clinicalefficacyandsafetyofomalizumabinconventionaltreatmentresistantvernalkeratoconjunctivitisourexperienceandliteraturereview